|
Cohorts
|
Length of Follow-Up (in Years)
|
|---|
|
N
|
%
|
Mean (SD)
|
Median
|
Interquartile Range
|
|---|
|
IPF Cohort
|
4,716
|
100.0
|
1.3 (1.4)
|
0.8
|
0.2 - 1.8
|
|
Reason for Censoring:
|
|
End of Study Period
|
1,537
|
32.6
|
1.8 (1.7)
|
1.3
|
0.5 - 2.7
|
|
Death
|
1,082
|
22.9
|
0.9 (1.1)
|
0.5
|
0.1 - 1.4
|
|
End of Health Plan Enrollment
|
1,289
|
27.3
|
1.2 (1.2)
|
0.9
|
0.3 - 1.8
|
|
Exclusion Criteria Observed
|
808
|
17.1
|
0.8 (1.0)
|
0.4
|
0.1 - 1.1
|
|
IPF Diagnostic Testing Subgroup
|
2,518
|
100.0
|
1.2 (1.4)
|
0.7
|
0.2 - 1.7
|
|
Reason for Censoring:
|
|
End of Study Period
|
793
|
31.5
|
1.8 (1.7)
|
1.2
|
0.5 - 2.7
|
|
Death
|
584
|
23.2
|
0.9 (1.1)
|
0.4
|
0.1 - 1.2
|
|
End of Health Plan Enrollment
|
661
|
26.3
|
1.2 (1.2)
|
0.8
|
0.3 - 1.8
|
|
Exclusion Criteria Observed
|
480
|
19.1
|
0.7 (0.9)
|
0.3
|
0.1 - 1.0
|
- Optum Research Database – Medicare Advantage Population. Cohort Entry: 01 January 2008 - 30 September 2014
- Abbreviations: IPF idiopathic pulmonary fibrosis, SD standard deviation
